0001883850-22-000058.txt : 20220817 0001883850-22-000058.hdr.sgml : 20220817 20220817160435 ACCESSION NUMBER: 0001883850-22-000058 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220815 FILED AS OF DATE: 20220817 DATE AS OF CHANGE: 20220817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MURPHY ANDREW J CENTRAL INDEX KEY: 0001796226 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 221173979 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-08-15 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001796226 MURPHY ANDREW J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Research Common Stock 2022-08-15 4 M 0 10000 179.13 A 68470 D Common Stock 2022-08-15 4 F 0 6487 634.25 D 61983 D Common Stock 2022-08-16 4 S 0 76 639.85 D 61907 D Common Stock 2022-08-16 4 S 0 148 640.91 D 61759 D Common Stock 2022-08-16 4 S 0 537 641.47 D 61222 D Common Stock 2022-08-16 4 S 0 329 642.53 D 60893 D Common Stock 2022-08-16 4 S 0 94 643.37 D 60799 D Common Stock 2022-08-16 4 S 0 332 644.49 D 60467 D Common Stock 2022-08-16 4 S 0 119 645.63 D 60348 D Common Stock 2022-08-16 4 S 0 325 646.44 D 60023 D Common Stock 2022-08-16 4 S 0 701 647.73 D 59322 D Common Stock 2022-08-16 4 S 0 766 648.78 D 58556 D Common Stock 2022-08-16 4 S 0 86 649.54 D 58470 D Common Stock 4290 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 179.13 2022-08-15 4 M 0 10000 0.0 D 2022-12-14 Common Stock 10000 10000 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 148 shares of Company stock on August 16, 2022 at prices ranging from $640.88 to $640.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. Represents volume-weighted average price of sales of 537 shares of Company stock on August 16, 2022 at prices ranging from $641.00 to $641.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. Represents volume-weighted average price of sales of 329 shares of Company stock on August 16, 2022 at prices ranging from $642.13 to $642.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. Represents volume-weighted average price of sales of 94 shares of Company stock on August 16, 2022 at prices ranging from $643.33 to $643.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. Represents volume-weighted average price of sales of 332 shares of Company stock on August 16, 2022 at prices ranging from $644.10 to $644.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. Represents volume-weighted average price of sales of 119 shares of Company stock on August 16, 2022 at prices ranging from $645.49 to $645.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. Represents volume-weighted average price of sales of 325 shares of Company stock on August 16, 2022 at prices ranging from $646.27 to $646.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. Represents volume-weighted average price of sales of 701 shares of Company stock on August 16, 2022 at prices ranging from $647.20 to $647.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. Represents volume-weighted average price of sales of 766 shares of Company stock on August 16, 2022 at prices ranging from $648.17 to $648.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2022 at each separate price. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Andrew Murphy 2022-08-17